Given the mounting evidence that G-CSF promote breast cancer metastasis in mouse models by acting on neutrophils to induce NETs as well as through other mechanisms, we hypothesized that patients who received G-CSF along with chemotherapy(s) have higher incidence of brain metastasis than those who did not receive G-CSF. The gene discussed is CSF3; the disease is breast carcinoma.